Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition
International Journal of Geriatric Psychiatry · 2023-10 · 38 (10)
DOI: 10.1002/gps.6015 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, online erschienen am 17.10.2023. Verfasst von Robert Haussmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Objectives
To determine the contribution of cerebral amyloid angiopathy to cognitive impairment in MCI and dementia.
Methods
Patients with subjective memory impairment (SMI), amnestic and non‐amnestic mild cognitive impairment ((n)aMCI), Alzheimer's disease (AD), mixed and vascular dementia (MD/VD) from our memory clinic were included in this retrospective analysis. Patients underwent neuropsychological testing and cranial magnetic resonance imaging (MRI). Magnetic resonance imaging data sets were analyzed regarding the presence of CAA‐related MRI biomarkers to determine CAA prevalence. ANOVAs were used to investigate the contribution of CAA to cognitive impairment within diagnostic groups and to determine whether differences in cognitive test performance between the diagnostic groups are mediated by total CAA burden.
Results
475 patients (222 male, 253 female) with SMI ( n = 47), naMCI ( n = 41), aMCI ( n = 189), early AD ( n = 9), AD ( n = 114), MD ( n = 71) and VD ( n = 4) were included. Mean age was 73.2 (9.9) years. CAA prevalence was 14.9% in SMI, 14.6% in naMCI, 24.3% in aMCI, 22.2% in early onset AD, 18.4% in late onset AD, 46.5% in MD and 25% in VD. Patients with possible and probable CAA were older than patients without CAA. In particular, diagnosis of aMCI, early onset AD, MD and VD showed high CAA prevalence. In AD but not in aMCI, CAA diagnosis significantly influenced test performance in the CERAD word list recall ( F (1,78) = 4505; p = 0.037; partial eta‐square = 0.055). Differences in cognitive test performance between the diagnostic groups of naMCI, aMCI, AD and MD were mediated by total CAA burden within AAT simply nouns subtest ( F (2,39) = 4059; p = 0.025; partial eta‐square = 0.172) and in CERAD verbal fluency test ( F (3,129) = 3533; p = 0.017; partial eta‐square = 0.076).
Conclusion
This retrospective analysis demonstrates high prevalence rates of CAA in cognitive diagnoses. Our data suggest that comorbid CAA independently impacts cognitive test performance in the course of AD with presumably stage‐dependent effects. Especially in patients with AD comorbid CAA additionally impairs memory function. Total CAA small vessel disease burden further modulates psychometric differences in cognitive test performance between diagnostic groups regarding word finding and word fluency capabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Department of Neuroradiology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Department of Neurology, University Hospital Carl Gustac Carus, Technische Universität Dresden, Dresden, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.
ORCID-Profile: Robert Haussmann
Zitieren
APA
Haussmann, R., Homeyer, P., Sauer, C., Grey, A., Krukowski, P., Brandt, M. D., Donix, M., & Linn, J. (2023). Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition. International Journal of Geriatric Psychiatry, 38(10). https://doi.org/10.1002/gps.6015
Vancouver
Haussmann R, Homeyer P, Sauer C, Grey A, Krukowski P, Brandt MD, et al. Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition. International Journal of Geriatric Psychiatry. 2023;38(10). doi:10.1002/gps.6015
BibTeX
@article{Haussmann2023,
author = {Haussmann, Robert and Homeyer, Patricia and Sauer, Cathrin and Grey, Arne and Krukowski, Pawel and Brandt, Moritz D and Donix, Markus and Linn, Jennifer},
title = {Comorbid cerebral amyloid angiopathy in dementia and prodromal stages—Prevalence and effects on cognition},
journal = {International Journal of Geriatric Psychiatry},
year = {2023},
volume = {38},
number = {10},
doi = {10.1002/gps.6015}
}
EUVIMED